Tacalyx GmbH

Facts

as of Nov 17, 2026

Glycan excellence against cancer. About us.

Legal name
Tacalyx GmbH
Headquarters
Berlin, Germany
Founded
2019
Employees
11-50estimated range
Register numbers
VAT DE325592676
Website
tacalyx.com

These are the key facts about Tacalyx GmbH on Alion as of Nov 17, 2026. Tacalyx GmbH is headquartered in Berlin, Germany. It was founded in 2019. The latest round is Seed of $11.9M, announced in 2026.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Tacalyx GmbH
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Berlin GermanyHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$11.9MTotal raised
SeedLatest round
2Rounds and grants
Money by yearUSD, rounds and grants
2026$11.9M1 record
2024-1 record
Largest rounds and grants
2026
$11.9M
Sources: funding announcements, grant and company registers

Milestones

Apr 29
Jun 12, 2024
Raised a round Seed · YahooFinance
2019
Founded
Each milestone is dated by its source: registers, filings, the press

Newsroom

Apr 302026
News · Pulse 2.0
Tacalyx, a biotech company focused on the discovery and development of cancer therapies directed at Tumor Associated Carbohydrate Antigens, has secured €11 million in a first clo…
Apr 292026
Press release · The Manila Times
Tacalyx Secures €11 Million to Advance Lead TACA-Targeting ADC Programme Toward the Clinic
Dec 2, 20252025
News · onvista
EQS-News: Tacalyx GmbH / Schlagwort(e): PersonalieTacalyx ernennt Jean Engela zum Chief Executive Officer für die nächste Wachstumsphase02.12.2025 / 10:00 CET/CESTFür den Inhal…
Jun 12, 20242024
News · YahooFinance
Tacalyx will use the funding to develop pipeline candidates and explore further partnership options to elevate its cancer research.
Sources: the outlets named on each headline, each story once